Instrument Inactif

Cours Cadence Pharmaceuticals, Inc.

Actions

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

06/05/14	Actavis : Factbox - M&A frenzy transforming global pharma
28/02/14	Cadence Pharmaceuticals, Inc. : Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Financial Results
17/02/14	Cadence Pharmaceuticals, Inc. : SHAREHOLDER DEADLINE: Law Office of Brodsky & Smith, LLC Announces Investigation of Cadence Pharmaceuticals, Inc. in Connection With the Sale of the Company to Mallinckrodt plc
14/02/14	Cadence Pharmaceuticals, Inc. : SHAREHOLDER DEADLINE: Law Office of Brodsky & Smith, LLC Announces Investigation of Cadence Pharmaceuticals, Inc.
13/02/14	Cadence Pharmaceuticals, Inc. : INVESTOR ALERT: LEVI & KORSINSKY, LLP Announces Investigation of CADENCE PHARMACEUTICALS INC. and Its Board of Directors in Connection with the Sale of the Company to Mallinckrodt plc -- CADX

Dirigeant	Titre	Age	Depuis
Bryan Reasons PSD	President	58	-
Diane K. Sheehan HRO	Responsable des Ressources Humaines	56	01/05/2006

Administrateur	Titre	Age	Depuis
Marvin R. Haselhorst BRD	Directeur/Membre du Conseil	-	19/03/2014
Bryan Reasons BRD	Directeur/Membre du Conseil	58	-

Ajouter à une liste 0 sélectionné Pour utiliser cette fonction vous devez être client ou membre Connexion Inscription	Varia.	Varia. 5j.	Varia. 1an	Varia. 3ans	Capi.($)
REGENERON PHARMACEUTICALS, INC.	+3,29%	+16,25%	+36,46%	+3,19%	76,15 Md
UCB	+2,72%	-9,39%	+20,58%	+172,43%	48,89 Md
SAMSUNG BIOLOGICS CO.,LTD.	-2,75%	+48,50%	+48,50%	+48,50%	47,83 Md
CSL LIMITED	-3,81%	+7,74%	-53,40%	-54,31%	41,37 Md
BIOGEN INC.	-2,40%	+0,38%	+53,81%	-24,64%	29,99 Md
INCYTE CORPORATION	-2,82%	+1,57%	+58,12%	+87,66%	24,23 Md
MODERNA, INC.	-5,35%	+1,39%	+98,59%	-51,89%	21,75 Md
INNOVENT BIOLOGICS, INC.	-1,59%	-3,61%	-6,77%	+150,58%	19,25 Md
SWEDISH ORPHAN BIOVITRUM AB	-0,42%	+2,89%	+77,99%	+128,67%	17,14 Md
Moyenne	-1,46%	+1,48%	+37,10%	+51,13%	36,29 Md
Moyenne pondérée par Capi.	-0,61%	+2,98%	+31,43%	+43,19%